In today’s episode, I’m diving into everything you need to know about Zepbound (tirzepatide) — the newest obesity medication now available in Canada. I’ll explain how this dual GIP/GLP-1 agonist works, how it’s different from semaglutide (Ozempic/Wegovy), and who it may be helpful for.

We’ll talk about expected weight loss results, side effects, cost, and access, as well as one really important topic: how to protect your muscle and bone health while on these medications. Rapid weight loss can come with downsides — and I’ll share what you can do to make sure your journey is sustainable and healthy.

In this episode, I cover:

→ How tirzepatide works and what makes it unique
→ Expected weight loss and blood sugar improvements
→ Common side effects and safety considerations
→ Tirzepatide vs. semaglutide — what’s the difference?
→ Cost, access, and insurance coverage in Canada
→ Why protein and strength training are essential during weight loss

As always, this podcast is for educational purposes only and not a substitute for personalized medical advice. Please talk to your doctor before making any changes to your treatment plan.

Come connect with me on Instagram @sashahighmd, and don’t forget to subscribe so you never miss a Monday episode!

Other episodes:

108. All About Wegovy
97. All About Mounjaro
53. All About Ozempic
145. Which one is better, Ozempic, Wegovy or Mounjaro?